Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health

http://www.fsg.org/Portals/0/Uploads/Documents/PDF/Competing_Saving_Lives.pdf
Authors: Peterson, Kyle; Kim, Samuel; Rehrig, Matthew; Stamp, Mike
Source: FSG
Year: 2012
Company Name: Abbott; AstraZeneca; BD; Eli Lilly and Company; GE; GlaxoSmithKline; Medtronic; Novartis; Novo Nordisk; Stryker
Number of pages: 62

[This document has not yet been rated] [You must be signed in as faculty to rate this document]   184 views

Abstract:

Increasingly, companies are seeing opportunities to meet the needs of underserved populations in low- and middle-income countries, where they once saw little commercial interest. This report highlights how pharmaceutical and medical device companies are creating shared value in global health by enhancing their competitiveness while simultaneously addressing the global burden of disease — often working in partnership with governments, funders, and nonprofit organizations.